Citius Pharmaceuticals, Inc. (CTXR)
Data as of , from SEC Form 4 filings.
See up to 3 months of CTXR. The 7-day demo opens the 1M and 3M ranges and puts CTXR on your watchlist.
Start 7-day demoLatest CTXR insider trades
About Citius Pharmaceuticals, Inc. (CTXR)
Citius Pharmaceuticals, Inc. files with the SEC under CIK 0001506251 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
CTXR Form 4 activity by transaction type, last 90 days
No Form 4 activity for CTXR in the last 90 days.
CTXR insider transactions (Form 4)
1811 Form 4 filings on record, the earliest from Nov 12, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Derivative | Warrant to Purchase Common Stock | 125,490 | - | - | ||
| Grant or award | Warrant to Purchase Common Stock | 125,490 | - | - | ||
| Derivative | Warrant to Purchase Common Stock | 89,388 | - | - | ||
| Grant or award | Warrant to Purchase Common Stock | 89,388 | - | - | ||
| Myron Z. Holubiak - Officer | Derivative | Warrant to Purchase Common Stock | 31,373 | - | - | |
| Myron Z. Holubiak - Officer | Grant or award | Warrant to Purchase Common Stock | 31,373 | - | - | |
| Myron Z. Holubiak - Officer | Derivative | Warrant to Purchase Common Stock | 22,344 | - | - | |
| Myron Z. Holubiak - Officer | Grant or award | Warrant to Purchase Common Stock | 22,344 | - | - | |
| Carol Webb - Director | Grant or award | Stock Option (Right to Purchase Common Stock) | 125,000 | $0.00 | - | |
| Robert Joseph Smith - Director | Grant or award | Stock Option (Right to Purchase Common Stock) | 125,000 | $0.00 | - | |
| Grant or award | Stock Option (Right to Purchase Common Stock) | 350,000 | $0.00 | - | ||
| Myron Czuczman - Officer | Grant or award | Stock Option (Right to Purchase Common Stock) | 300,000 | $0.00 | - | |
| Grant or award | Stock Option (Right to Purchase Common Stock) | 125,000 | $0.00 | - | ||
| Eugene Myron Holuka - Director | Grant or award | Stock Option (Right to Purchase Common Stock) | 125,000 | $0.00 | - | |
| Grant or award | Stock Option (Right to Purchase Common Stock) | 600,000 | $0.00 | - | ||
| Dennis M. McGrath - Director | Grant or award | Stock Option (Right to Purchase Common Stock) | 125,000 | $0.00 | - | |
| Myron Z. Holubiak - Officer | Grant or award | Stock Option (Right to Purchase Common Stock) | 350,000 | $0.00 | - | |
| Myron Z. Holubiak - Officer | Grant or award | Stock Option (Right to Buy) | 75,000 | $0.00 | - |
CTXR insider trading FAQ
What is the latest insider trade for CTXR?
Citius Pharmaceuticals, Inc. (CTXR) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-08-08. The full record for CTXR runs to 11 Form 4 filings, the earliest from 2024-11-12. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CTXR stock?
No insider purchases of CTXR were filed in the last 90 days.
How many insiders are selling CTXR stock?
No insider sales of CTXR were filed in the last 90 days.
Where can I see CTXR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CTXR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Leonard L. Mazur view on EDGAR
- - Myron Z. Holubiak view on EDGAR
- - Carol Webb view on EDGAR
- - Robert Joseph Smith view on EDGAR
- - Jaime Bartushak view on EDGAR
- - Myron Czuczman view on EDGAR
- - Suren G. Dutia view on EDGAR
- - Eugene Myron Holuka view on EDGAR
- - Leonard L. Mazur
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CTXR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CTXR with a 7-day demo
- CTXR on your watchlist
- Every CTXR Form 4 filing on record
- Up to 3 months of CTXR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive